NETRAMARK SIGNS CONTRACT WITH PHARMACEUTICAL COMPANY TO DELIVER CLINICAL TRIAL INSIGHTS REGARDING...
NetraMark Presenting New Data Showing Ability of Its Proprietary NetraAI Clinical Trial Solution in PD Insights
NETRAMARK'S AI-BASED CLINICAL SOLUTION IDENTIFIES PARKINSON'S DISEASE SUBTYPES LINKED BY MITOCHON...
NETRAMARK'S AI-BASED TECHNOLOGY IDENTIFIES SIGNIFICANT DRIVERS OF EFFICACY AND PLACEBO RESPONSES...
NETRAMARK ANNOUNCES LAUNCH OF THE NETRA AI LAB
NetraMark Up 8.6% After Reporting Third Contract With Biopharmaceutical Firm
NETRAMARK SIGNS THIRD CONTRACT WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL...
NetraMark's Generative AI Discovers Novel Rare Disease Drug Targets and Unique Patient Subpopulat...
NETRAMARK SIGNS TWO CONTRACTS WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL...
NETRAMARK SELECTS FINN PARTNERS AS ITS PUBLIC RELATIONS AGENCY OF RECORD
NETRAMARK SIGNS MASTER SERVICE AGREEMENT WITH A LARGE BIOPHARMACEUTICAL COMPANY
NETRAMARK PRIVATE PLACEMENT - PRESS RELEASE CLARIFICATION
NETRAMARK ANNOUNCES PRIVATE PLACEMENT FINANCING
PHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ADVISORY BOARD
NETRAMARK ANNOUNCES SHARES FOR DEBT SETTLEMENT
The Power Play by The Market Herald Releases New Interviews With NetraMark Holdings, CANEX Metals, Green River Gold and Nextech3D.ai Discussing Their Latest News
No Data